Evaluating Outcomes and Response Profiles of a Psychological Treatment for People With Chronic Pain

Wayne State University1 site in 1 country72 target enrollmentSeptember 2008

ConditionsChronic Musculoskeletal Pain

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Chronic Musculoskeletal Pain
Sponsor: Wayne State University
Enrollment: 72
Locations: 1
Primary Endpoint: Brief Pain Inventory
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This interventional study seeks to evaluate the overall outcomes of a novel, emotional awareness intervention for people with chronic musculoskeletal pain and determine which patients benefit the most from this intervention. The investigators also are evaluating the effects of brief emotional communication technique embedded in the pre-treatment assessment.

Registry

clinicaltrials.gov

Start Date

September 2008

End Date

November 2011

Last Updated

13 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Wayne State University

Responsible Party

Principal Investigator

Mark A. Lumley

Professor

Wayne State University

Eligibility Criteria

Inclusion Criteria

•Adults with chronic musculoskeletal pain, not accounted for by disease or tissue pathology, who are seeking or referred for this psychological treatment program

Exclusion Criteria

•Autoimmune diseases
•Cancer pain
•Illiterate
•Cognitively impaired
•Too medically ill

Outcomes

Primary Outcomes

Brief Pain Inventory

Time Frame: baseline, post-treatment, 3- and 6-month follow-ups

Secondary Outcomes

Center for Epidemiologic Studies--Depression Scale(baseline, post-treatment, 3- and 6-month follow-ups)
Satisfaction with Life Scale(baseline, post-treatment, 3- and 6-month follow-ups)
McGill Pain Questionnaire(baseline, post-treatment, 3- and 6-month follow-ups)
Impact of Events Scale-Revised(baseline, post-treatment, 3- and 6-month follow-ups)
Positive Affect Negative Affect Scale-Expanded Version(baseline, post-treatment, 3- and 6-month follow-ups)